US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Polyrizon Ltd.

10.30

-0.1900-1.81%

Post-market: 10.00-0.3000-2.91%16:30 EDT

Volume:23.20K

Turnover:241.08K

Market Cap:21.46M

PE:-2.10

High:10.86

Open:10.86

Low:10.25

Close:10.49

52wk High:18.20

52wk Low:2.88

Shares:2.08M

Float Shares:1.65M

Volume Ratio:0.20

T/O Rate:1.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.9017

ROE:-25.38%

ROA:-28.95%

PB:1.02

PE(LYR):- -

Loading ...

Overview Company News Filings

Polyrizon Advances Nasarix Study With 3 Major US Trial Sites

MT Newswires Live

Polyrizon signs agreements with two additional clinical sites for Nasarix study

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for Nasarix™ Trial

THOMSON REUTERS

Polyrizon: Co & Arrow Aviation Entered Into Letter Agreement Extending Exclusivity Period & Initial Negotiation Period Under Mou to June 30

THOMSON REUTERS

Polyrizon appoints Ami Oren as Class I director

Polyrizon signs first U.S. clinical trial agreement for NASARIX allergy blocker study

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for Nasarix™ Allergy Blocker Clinical Trial

THOMSON REUTERS

Polyrizon expands U.S. patent claims for intranasal drug delivery platform

Polyrizon Ltd trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM

Polyrizon files European patent application for Trap & Target platform

Polyrizon: Announces Filing of European Patent Application for Its Drug Delivery Platform - SEC Filing

THOMSON REUTERS

Polyrizon files to sell 0.5M shares of common stock for holders

Polyrizon closes unregistered private placement, raises $3.5 million

Polyrizon sells unregistered warrants in $3.5 million private placement

BRIEF-Polyrizon Ltd - Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants

Polyrizon Ltd - Expects Aggregate Gross Proceeds of $3.5 Mln From Offering and Private Placement

THOMSON REUTERS

Polyrizon Ltd - Enters Agreements for Registered Direct Offering of Ordinary Shares and Pre-Funded Warrants

THOMSON REUTERS

Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement

Polyrizon Director Oz Adler disposes of USD 0.0 million common shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PLRZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":10.3,"timestamp":1787342400000,"preClose":10.49,"halted":0,"volume":23198,"hourTrading":{"tag":"盘后","latestPrice":10,"preClose":10.3,"latestTime":"16:30 EDT","volume":2024,"amount":20442.55,"timestamp":1787344206189,"change":-0.3,"changeRate":-0.029126,"amplitude":0.029126},"delay":0,"changeRate":-0.01811248808388937,"floatShares":1648899,"shares":2083979,"eps":-4.901672,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-21 16:00:00 EDT","open":10.86,"high":10.86,"low":10.252,"amount":241082.77921,"amplitude":0.05796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.901672,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":10.49,"preHourTrading":{"tag":"盘前","latestPrice":10.98,"preClose":10.49,"latestTime":"08:45 EDT","volume":10,"amount":109.80000000000001,"timestamp":1787316350024,"change":0.49,"changeRate":0.046711,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":10,"preClose":10.3,"latestTime":"16:30 EDT","volume":2024,"amount":20442.55,"timestamp":1787344206189,"change":-0.3,"changeRate":-0.029126,"amplitude":0.029126},"volumeRatio":0.19734782522234245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":1648899,"roa":"-28.95%","roe":"-25.38%","lyrEps":0,"volumeRatio":0.19734782522234245,"shares":2083979,"dividePrice":0,"high":10.86,"amplitude":0.05796,"preClose":10.49,"low":10.252,"week52Low":2.88,"pbRate":"1.02","week52High":18.2,"institutionHeld":0,"latestPrice":10.3,"eps":-4.901672,"divideRate":0,"volume":23198,"delay":0,"ttmEps":-4.901672,"open":10.86,"prevYearClose":8.49,"prevWeekClose":10.98,"prevMonthClose":11.25,"prevQuarterClose":12.52,"fiveDayClose":10.98,"twentyDayClose":14.68,"sixtyDayClose":16.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-28","symbol":"PLRZ","defaultRemindTime":1764340200000,"type":"split","dateTimestamp":1764306000000,"forFactor":6,"toFactor":1,"ratio":6},{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2026-08-21","current":-2.101324,"percent":0.592018,"low":-29.515607,"twenty":-11.696628,"median":-6.632,"eighty":-3.047315,"high":-0.011381,"avg":-7.999682,"sd":6.110678,"marketCap":19635685},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-18","current":-3.343916,"twenty":-4.728069,"median":-3.039365,"eighty":-0.942596,"marketCap":5166350},{"date":"2025-07-25","current":-4.793774,"twenty":-4.784488,"median":-3.066787,"eighty":-0.954976,"marketCap":7406381},{"date":"2025-08-01","current":-9.134632,"twenty":-4.922267,"median":-3.137242,"eighty":-0.969039,"marketCap":14113006},{"date":"2025-08-08","current":-8.476938,"twenty":-5.004125,"median":-3.155299,"eighty":-0.973817,"marketCap":13096869},{"date":"2025-08-15","current":-8.18463,"twenty":-5.134029,"median":-3.19779,"eighty":-0.976803,"marketCap":12645253},{"date":"2025-08-22","current":-7.746168,"twenty":-5.410414,"median":-3.21607,"eighty":-0.982233,"marketCap":11967829},{"date":"2025-08-29","current":-7.600014,"twenty":-5.856236,"median":-3.245278,"eighty":-0.987228,"marketCap":11742021},{"date":"2025-09-05","current":-7.819245,"twenty":-6.049761,"median":-3.325781,"eighty":-0.992223,"marketCap":12080733},{"date":"2025-09-12","current":-7.143282,"twenty":-6.209629,"median":-3.343916,"eighty":-1.006667,"marketCap":11036370},{"date":"2025-09-19","current":-10.354516,"twenty":-6.696876,"median":-3.375088,"eighty":-1.026648,"marketCap":11742021},{"date":"2025-09-26","current":-11.070023,"twenty":-7.035762,"median":-3.443585,"eighty":-1.030557,"marketCap":12553406},{"date":"2025-10-03","current":-11.383325,"twenty":-7.364852,"median":-3.487865,"eighty":-1.042883,"marketCap":12908691},{"date":"2025-10-10","current":-13.054272,"twenty":-7.512322,"median":-3.569805,"eighty":-1.058791,"marketCap":14803545},{"date":"2025-10-17","current":-11.174457,"twenty":-7.59231,"median":-3.644879,"eighty":-1.068565,"marketCap":12671834},{"date":"2025-10-24","current":-11.278891,"twenty":-7.731553,"median":-3.707687,"eighty":-1.123948,"marketCap":12790262},{"date":"2025-10-31","current":-10.75672,"twenty":-7.950784,"median":-3.905854,"eighty":-1.280758,"marketCap":12198121},{"date":"2025-11-07","current":-9.567215,"twenty":-8.038476,"median":-3.996712,"eighty":-1.310622,"marketCap":10849222},{"date":"2025-11-14","current":-8.045608,"twenty":-8.360015,"median":-4.312242,"eighty":-1.376104,"marketCap":9123720},{"date":"2025-11-21","current":-6.109399,"twenty":-8.170015,"median":-4.417419,"eighty":-1.474489,"marketCap":6928059},{"date":"2025-11-28","current":-5.587228,"twenty":-8.111553,"median":-4.501561,"eighty":-1.508371,"marketCap":6335917},{"date":"2025-12-05","current":-25.23826,"twenty":-8.403861,"median":-4.535397,"eighty":-1.515701,"marketCap":28620187},{"date":"2025-12-12","current":-21.591766,"twenty":-8.696169,"median":-4.627772,"eighty":-1.520317,"marketCap":24485063},{"date":"2025-12-19","current":-17.597159,"twenty":-9.06593,"median":-4.711914,"eighty":-1.541633,"marketCap":19955178},{"date":"2025-12-26","current":-13.245735,"twenty":-9.27961,"median":-4.754698,"eighty":-1.546299,"marketCap":15020663},{"date":"2026-01-02","current":-14.777436,"twenty":-10.201257,"median":-4.798393,"eighty":-1.579229,"marketCap":16757612},{"date":"2026-01-09","current":-23.341039,"twenty":-10.662157,"median":-4.922267,"eighty":-1.630419,"marketCap":26468738},{"date":"2026-01-16","current":-21.842963,"twenty":-11.038692,"median":-4.999213,"eighty":-1.702674,"marketCap":24769920},{"date":"2026-01-23","current":-22.02569,"twenty":-11.165081,"median":-5.003554,"eighty":-1.780942,"marketCap":24977133},{"date":"2026-01-30","current":-18.441421,"twenty":-11.278891,"median":-5.035187,"eighty":-1.871075,"marketCap":20912571},{"date":"2026-02-06","current":-17.471559,"twenty":-11.383325,"median":-5.167341,"eighty":-1.959036,"marketCap":19812748},{"date":"2026-02-13","current":-19.664289,"twenty":-11.445985,"median":-5.322255,"eighty":-2.161828,"marketCap":22299304},{"date":"2026-02-20","current":-19.158274,"twenty":-11.780175,"median":-5.500199,"eighty":-2.356399,"marketCap":21725483},{"date":"2026-02-27","current":-19.24261,"twenty":-12.048622,"median":-5.587228,"eighty":-2.377712,"marketCap":21821120},{"date":"2026-03-06","current":-19.130163,"twenty":-12.337157,"median":-5.805751,"eighty":-2.404957,"marketCap":21693605},{"date":"2026-03-13","current":-21.491564,"twenty":-13.089202,"median":-5.977481,"eighty":-2.428961,"marketCap":24371434},{"date":"2026-03-20","current":-18.975548,"twenty":-13.87234,"median":-6.068669,"eighty":-2.429444,"marketCap":21518271},{"date":"2026-03-27","current":-6.571741,"twenty":-14.681705,"median":-6.104823,"eighty":-2.432754,"marketCap":21916757},{"date":"2026-04-02","current":-6.133576,"twenty":-14.29878,"median":-6.093857,"eighty":-2.438272,"marketCap":20455475},{"date":"2026-04-10","current":-5.228861,"twenty":-14.168236,"median":-6.058175,"eighty":-2.459999,"marketCap":17438252},{"date":"2026-04-17","current":-5.848317,"twenty":-13.976774,"median":-5.969011,"eighty":-2.460689,"marketCap":19504138},{"date":"2026-04-24","current":-7.906455,"twenty":-13.454603,"median":-6.058175,"eighty":-2.469311,"marketCap":26368026},{"date":"2026-05-01","current":-8.924253,"twenty":-13.245735,"median":-6.093519,"eighty":-2.483106,"marketCap":29762383},{"date":"2026-05-08","current":-7.936411,"twenty":-13.245735,"median":-6.109399,"eighty":-2.496901,"marketCap":26467930},{"date":"2026-05-15","current":-8.430332,"twenty":-13.097935,"median":-6.18242,"eighty":-2.517594,"marketCap":28115156},{"date":"2026-05-22","current":-7.100113,"twenty":-13.054272,"median":-6.295839,"eighty":-2.548287,"marketCap":23678877},{"date":"2026-05-29","current":-9.261017,"twenty":-12.817554,"median":-6.483666,"eighty":-2.548563,"marketCap":30885492},{"date":"2026-06-05","current":-7.184304,"twenty":-12.577356,"median":-6.653598,"eighty":-2.591548,"marketCap":23959654},{"date":"2026-06-12","current":-6.49955,"twenty":-12.378931,"median":-6.640969,"eighty":-2.628587,"marketCap":21675999},{"date":"2026-06-18","current":-7.425652,"twenty":-12.330195,"median":-6.571741,"eighty":-2.650742,"marketCap":24764549},{"date":"2026-06-26","current":-6.409746,"twenty":-12.260573,"median":-6.632,"eighty":-2.70965,"marketCap":21376504},{"date":"2026-07-02","current":-7.116951,"twenty":-12.177025,"median":-6.653598,"eighty":-2.796579,"marketCap":23735032},{"date":"2026-07-10","current":-8.059891,"twenty":-12.10238,"median":-6.750178,"eighty":-2.921331,"marketCap":26879737},{"date":"2026-07-17","current":-7.296559,"twenty":-12.01284,"median":-7.006752,"eighty":-2.995391,"marketCap":24334024},{"date":"2026-07-24","current":-8.593101,"twenty":-11.905496,"median":-7.027147,"eighty":-3.017632,"marketCap":28657992},{"date":"2026-07-31","current":-6.522001,"twenty":-11.884609,"median":-7.027147,"eighty":-3.030526,"marketCap":21750873},{"date":"2026-08-07","current":-6.449035,"twenty":-11.801062,"median":-6.876942,"eighty":-3.037515,"marketCap":21507533},{"date":"2026-08-14","current":-6.033693,"twenty":-11.780175,"median":-6.701609,"eighty":-3.042447,"marketCap":20122366},{"date":"2026-08-21","current":-5.887762,"twenty":-11.696628,"median":-6.632,"eighty":-3.047315,"marketCap":19635685}],"updateTime":1787510289087},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641915487","title":"Polyrizon Advances Nasarix Study With 3 Major US Trial Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2641915487","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641915487?lang=en_us&edition=fundamental","pubTime":"2026-06-08 21:51","pubTimestamp":1780926678,"startTime":"0","endTime":"0","summary":"Polyrizon  has secured agreements with three US clinical sites for its upcoming Nasarix trial, marking a key step toward initiating its multi-center study in seasonal allergic rhinitis, the company said Monday.The sites represent major enrollment centers expected to support patient recruitment for the study evaluating the safety, tolerability and efficacy of its intranasal hydrogel allergy blocker.Polyrizon said the trial will compare Nasarix with saline spray in patients with seasonal allergic rhinitis, with up to five US sites expected to participate in total.Shares of Polyrizon were down more than 3% in Monday trading.Price: 12.73, Change: -0.48, Percent Change: -3.63","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641580487","title":"Polyrizon signs agreements with two additional clinical sites for Nasarix study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641580487","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641580487?lang=en_us&edition=fundamental","pubTime":"2026-06-08 21:37","pubTimestamp":1780925839,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced it has signed agreements with two additional U.S. clinical sites. This brings the total to three major contracted sites ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-signs-agreements-with-two-additional-clinical-sites-for-nasarix-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-signs-agreements-with-two-additional-clinical-sites-for-nasarix-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641348221","title":"Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for Nasarix™ Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641348221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641348221?lang=en_us&edition=fundamental","pubTime":"2026-06-08 21:25","pubTimestamp":1780925100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA87LTMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641914704","title":"Polyrizon: Co & Arrow Aviation Entered Into Letter Agreement Extending Exclusivity Period & Initial Negotiation Period Under Mou to June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2641914704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641914704?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:24","pubTimestamp":1780691049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636309","title":"Polyrizon appoints Ami Oren as Class I director","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636309","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636309?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:26","pubTimestamp":1779913603,"startTime":"0","endTime":"0","summary":"Polyrizon appointed Ami Oren as a Class I director, effective May 14, 2026.Oren, 51, founded and ran Hummus Ami from 2015 to 2026, overseeing finance, procurement, staffing, customer experience.He exited the business through a sale; earlier operated an independent catering and culinary operation for large-scale events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3bLwkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635975780","title":"Polyrizon signs first U.S. clinical trial agreement for NASARIX allergy blocker study","url":"https://stock-news.laohu8.com/highlight/detail?id=2635975780","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635975780?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678740,"startTime":"0","endTime":"0","summary":"Polyrizon signed first U.S. clinical trial agreement with an allergy-focused clinical research site in Texas to start human testing of NASARIX  seasonal allergic rhinitis nasal spray.Texas site set to serve as first center in planned multi-center study comparing PL-14 efficacy, safety, tolerability versus saline spray.Agreement marks initial U.S. site activation step ahead of planned first-in-human clinical program; additional sites expected in coming months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL1lwgMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","PLRZ","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4139","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780617","title":"Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for Nasarix™ Allergy Blocker Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780617?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA68YTHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955811","title":"Polyrizon expands U.S. patent claims for intranasal drug delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955811?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:54","pubTimestamp":1777899256,"startTime":"0","endTime":"0","summary":"Polyrizon submitted amended claims in a U.S. patent application to broaden protection for its intranasal drug-delivery hydrogel platform beyond core mucoadhesive composition to cover drug-delivery systems and methods of use.Claims target formulations using sulfated polysaccharide polymers with additional polymer components designed to form a continuous film on contact with nasal mucosa, aiming to increase drug residence time and improve bioavailability.Move supports strategy to strengthen intellectual property position for intranasal delivery across local and systemic drug administration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electron","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL11KcPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630585230","title":"Polyrizon Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2630585230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630585230?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:31","pubTimestamp":1777386663,"startTime":"0","endTime":"0","summary":"09:58 EDT Polyrizon (PLRZ) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-movin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630058825","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:58 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2630058825","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630058825?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:58","pubTimestamp":1777384732,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:58 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nAQN2LWI02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630397423","title":"Polyrizon files European patent application for Trap & Target platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2630397423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630397423?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:57","pubTimestamp":1777298252,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced the filing of a divisional patent application with the Europe Patent Office for its Trap & Target platform technology. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-files-european-patent-application-for-trap-target-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-files-european-patent-application-for-trap-target-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU1244550221.USD","LU2237443382.USD","BK4532","BK4588","LU0052756011.USD","LU0211328371.USD","LU0128525689.USD","BK4155","BK4597","LU0310799852.SGD","LU1244550494.USD","LU2237443622.USD","BK4114","TGT","LU1267930227.SGD","LU2237443549.SGD","LU0823411888.USD","BK4139","LU0211327993.USD","LU0310800965.SGD","LU1267930490.SGD","PLRZ","BK4585","BK4504","LU1244550577.SGD","BK4596","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630392431","title":"Polyrizon: Announces Filing of European Patent Application for Its Drug Delivery Platform - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630392431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630392431?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:33","pubTimestamp":1777296806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629286426","title":"Polyrizon files to sell 0.5M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2629286426","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629286426?lang=en_us&edition=fundamental","pubTime":"2026-04-24 07:30","pubTimestamp":1776987028,"startTime":"0","endTime":"0","summary":"19:28 EDT Polyrizon (PLRZ) files to sell 0.5M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-files-to-sell-0-5m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-files-to-sell-0-5m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626892299","title":"Polyrizon closes unregistered private placement, raises $3.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2626892299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626892299?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:20","pubTimestamp":1775679608,"startTime":"0","endTime":"0","summary":"Polyrizon closed a $3.5 million registered direct offering with a concurrent unregistered private placement with a single institutional investor.Private placement issued 111,111 pre-funded warrants with 388,888 common warrants at a $9 unit price.Net proceeds earmarked for general corporate purposes, working capital.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL2WzwpS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014039.USD","BK4139","IE00BN0W2V16.EUR","BK4588","PLRZ","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","BK4112","BK4585","LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625559509","title":"Polyrizon sells unregistered warrants in $3.5 million private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625559509","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625559509?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:21","pubTimestamp":1775568115,"startTime":"0","endTime":"0","summary":"Polyrizon priced a concurrent private placement with a single institutional investor alongside a registered direct offering, targeting aggregate gross proceeds of about USD 3.5 million.Private placement includes 111,111 pre-funded warrants, each exercisable for 1 ordinary share.Investor also receives 388,888 common warrants with an exercise price of USD 9 per share.Post-transaction share count is expected to be 2,083,939 ordinary shares outstanding assuming exercise of all pre-funded warrants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL2ds3W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930913","title":"BRIEF-Polyrizon Ltd - Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930913?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:05","pubTimestamp":1775563521,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Ltd - Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded WarrantsApril 7 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD - ENTERS AGREEMENTS FOR REGISTER","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930371","title":"Polyrizon Ltd - Expects Aggregate Gross Proceeds of $3.5 Mln From Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930371","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930371?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625303459","title":"Polyrizon Ltd - Enters Agreements for Registered Direct Offering of Ordinary Shares and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2625303459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625303459?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625587049","title":"Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625587049","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625587049?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563200,"startTime":"0","endTime":"0","summary":"RAANANA, ISRAEL, April  07, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3269086/0/en/Polyrizon-Ltd-Announces-3-5-Million-Registered-Direct-Offering-and-Private-Placement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624492265","title":"Polyrizon Director Oz Adler disposes of USD 0.0 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624492265","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624492265?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:16","pubTimestamp":1775074572,"startTime":"0","endTime":"0","summary":"Polyrizon director Oz Adler sold 3,292 ordinary shares on March 31, 2026.Direct holdings fell to 19,850 ordinary shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2fqVnf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Polyrizon Director Oz Adler disposes of USD 0.0 million common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}]}}